Natural history of localised prostatic cancer. A population-based study in 223 untreated patients.
about
Prevention. How much harm? How much benefit? 2. Ten potential pitfalls in determining the clinical significance of benefits.Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer.Prostate cancer. Finding and managing it.Molecular markers for prostate cancer metastasis. Developing diagnostic methods for predicting the aggressiveness of prostate cancer.Hormone resistant prostatic adenocarcinoma. An evaluation of prognostic factors in pre- and post-treatment specimens.Prostatic carcinoma: a multivariate analysis of prognostic factors.Measures of mortality in prostatic cancer.A retrospective study of high mobility group protein I(Y) as progression marker for prostate cancer determined by in situ hybridization.Expectant management: an option for localized prostate cancer.Watchful waiting for prostate cancer: a review article.What is the risk posed by prostate cancer?Screening for prostate cancer. How can patients give informed consent?Localised carcinoma of the prostate: a paradigm of uncertainty.Neodymium-YAG laser treatment in localized prostatic cancer. High rate of local failure.Treatment of early prostatic cancer.Prostate cancer: to screen or not to screen.Role of histopathology and molecular markers in the active surveillance of prostate cancer.Radical surgery versus radiation therapy in early prostatic carcinoma.Is Prostate Biopsy Recommended in Turkish Men with a Prostate-Specific Antigen Level between 2.5 and 4 ng/mL?Matrix metalloproteinase 9 expression in primary human prostatic adenocarcinoma and benign prostatic hyperplasia.Procoagulant activity may be a marker of the malignant phenotype in experimental prostate cancer.Screening for prostatic cancer.Deferred therapy in well and moderately differentiated prostate cancer.The prostate cancer pseudo-epidemic.Recall of pretreatment symptoms among men treated with radiotherapy for prostate cancer.Quality of life and symptoms in a randomized trial of radiotherapy versus deferred treatment of localized prostate carcinoma.Prostate cancer practice patterns and quality of life: the Prostate Cancer Outcomes Study.Prostate cancer in northern Sweden. Incidence, survival and mortality in relation to tumour grade.The Role of Radical Surgery in the Treatment of Prostatic Cancer
P2860
Q34711960-C93574AE-9473-4D6F-88FE-652B1EA620F8Q34775924-FE39DEB1-19C1-4C51-9164-022EE268A773Q35324634-97BF48DA-5FE3-4788-B0AD-E94296258305Q35764421-012FD7F4-AED3-4B3C-A30B-9023AB8E885EQ35977233-5793C20A-DAFC-4F2C-9095-104777FC6E2AQ35978450-7CBE2AAA-0FDC-453F-A11E-61DC5FA9DBA3Q35981298-F6E29F60-01A7-44CC-BDD3-E5582264F19CQ36135924-5CD2A9E0-F6BF-4448-AD04-3676B2B88C5EQ36244110-9452D769-4F8E-44DD-A2C3-8DD2983C806BQ36364398-A4BC3BA3-7DA6-4959-8650-0F46F75F3E85Q36520479-A335AFD8-C513-42B3-AFB6-EB755453D80CQ36652961-C71AA4C0-E6D8-412E-87EA-2A9B7E029F52Q36728319-7A284A99-3E4A-4537-921E-490903FC05B2Q36747559-3CCA9EAC-0D92-4EBB-B0D4-C66951689239Q37713508-5946F028-4257-428B-BEEC-8D009E596F80Q37713519-13C93B76-7018-4781-BCFD-62A16AD6BA54Q37878468-8E6CA27C-E287-4210-A6AE-8048D1A575E5Q39255402-51004698-3C19-4356-954F-0C82C350C5EBQ41097956-0C8DC4EA-DFD3-4841-AB80-0F272F737C11Q42389455-3EEC7004-A6A0-48B7-9DDD-C2C50944A3CAQ42389635-2FD95B33-B577-4A90-B27A-CA534698E98AQ43731213-CFF88707-0486-4649-ADA2-9E80A1B7B432Q44354051-EA4A68F7-BBD6-4967-8575-FA0B6A14CD74Q45297532-5D71E953-8720-49E9-9AC1-CEB3A865D985Q51926635-F31A1835-04D7-4926-92BD-4276D7B36179Q53460878-4D8A5138-3F77-4D05-A519-0ADB02E14F9CQ53539881-98634C0D-A6E3-4F24-AE85-5324EBCBD1ABQ53975141-EB0C37E0-820B-4AD7-804C-8335D01E6896Q58276464-A641523B-F001-40EF-9DB8-56F271E0E8A8
P2860
Natural history of localised prostatic cancer. A population-based study in 223 untreated patients.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh-hant
name
Natural history of localised p ...... udy in 223 untreated patients.
@en
Natural history of localised p ...... udy in 223 untreated patients.
@nl
type
label
Natural history of localised p ...... udy in 223 untreated patients.
@en
Natural history of localised p ...... udy in 223 untreated patients.
@nl
prefLabel
Natural history of localised p ...... udy in 223 untreated patients.
@en
Natural history of localised p ...... udy in 223 untreated patients.
@nl
P2093
P1433
P1476
Natural history of localised p ...... udy in 223 untreated patients.
@en
P2093
J E Johansson
R Bergström
S O Andersson
U B Krusemo
P304
P356
10.1016/S0140-6736(89)92269-1
P407
P577
1989-04-01T00:00:00Z